Merck stock tumbled Thursday as the coronavirus pandemic contributed to a sluggish first quarter, though the company's 2021 outlook remained strong.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,